In‑ovo PCR sexing and genotyping point to embryonic day 7 as the sweet spot
A new Scientific Reports paper presents the most detailed evaluation to date of early in‑ovo sexing and genotyping using PCR‑based techniques in chickens, offering timely insights for poultry breeders, hatcheries and research institutes striving to comply with tightening welfare regulations and reduce surplus male chick culling.
The study tested more than 800 eggs across multiple chicken lines – including commercial layers and a genetically-modified research line – using a simple workflow combining whole‑genome amplification, Kompetitive Allele Specific PCR (KASP), and standard endpoint PCR. The results point clearly to embryonic day 7 (ED7) as the optimal time for sampling.
A practical, accurate method for small‑scale and research settings
While industrial automated systems for sexing at ED8-10 already exist, many laboratories lack access to high‑throughput platforms. This study set out to create an accessible method using standard laboratory equipment. Researchers successfully applied their workflow across ED4–ED10, but found that results became progressively more reliable as incubation advanced.
At early stages (ED4–ED6), DNA yields were low and sample quality inconsistent, lowering PCR success rates to around 70-80%. By ED7, both success and accuracy improved sharply, delivering 92-100% identification accuracy for both sexing and genotyping across experiments.
The whole‑genome amplification step proved essential, overcoming the very low DNA content typical of early embryonic fluids. KASP and multiplex PCR performed effectively at later stages, though KASP required occasional reruns due to fluorescence cluster ambiguities – likely influenced by uric‑acid‑rich allantoic fluid.
Why ED7 works best
The authors provided a clear biological rationale for ED7 as the preferred sampling window. Shell‑less culture imaging demonstrated that the allantoic sac expands substantially between ED6 and ED7, offering a larger, more consistent reservoir of targetable fluid while reducing the risk of puncturing the amnion.
Early samples (ED4–ED6) often contained “yellowish” sub‑embryonic fluid, which is less suited for DNA extraction, corresponding to a developmental stage where the embryo is more sensitive to disturbance. By contrast, ED7 fluid was consistently clear, with higher DNA content and far better PCR performance.
ED7 also balances ethical considerations: it enables accurate sex determination before ED13, the stage at which nociception (pain perception) is believed to begin.
Hatchability: minimal impact when done correctly
The study assessed hatchability across thousands of eggs in 3 major phases. Results were reassuring:
- Phase I (Araucana × White Leghorn): Punctured eggs hatched at 84% vs. 92% in controls; the difference reached statistical significance, though mid‑embryonic mortality differences were not significant.
- Phase II (commercial brown and white layers): Hatch rates improved steadily from ED4 to ED7, reaching 87% (brown) and 97% (white) at ED7. No evidence suggested the ED7 puncture harmed hatchability.
- Phase III (genetically-modified iCaspase9 line): Embryo survival was 92% in punctured eggs vs. 96% in controls, with no significant difference.
Across all lines, ED7 significantly reduced sampling difficulty and embryonic losses. Early sampling (especially ED6) often required repeated puncture attempts – up to 25% of eggs – which increased risk.
A tool for reducing surplus male chicks
The authors emphasise that this method supports the 3Rs principles (Replacement, Reduction, Refinement) by enabling removal of unwanted male or genetically unsuitable embryos before hatching. This is especially relevant where legislation bans culling of day‑old chicks, including in France and Germany, and where research institutes must minimise surplus animals.
For breeding programmes using genetically-modified or specialised research lines, early genotyping also reduces the need to rear non‑useful birds.
Implications for industry and research
Although the study focuses on laboratory rather than industrial throughput, the findings provide valuable guidance:
- ED7 is the optimal intersection of accuracy, welfare and hatchability.
- The method is low‑cost, reproducible, and adaptable, suitable for small research labs and niche breeders.
- Early PCR‑based genotyping could complement or validate emerging non‑invasive sexing technologies already entering the market.
Conclusion
This comprehensive evaluation confirms that in‑ovo PCR sexing and genotyping at ED7 offers a robust, ethically preferable and technically accessible approach. While not intended to replace industrial automated systems, it fills an important gap for research institutions and small‑scale breeding operations and strengthens the scientific case for reducing surplus chick production while maintaining high welfare standards.
Join 31,000+ subscribers
Subscribe to our newsletter to stay updated about all the need-to-know content in the poultry sector, three times a week.
